2 completed, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
Follow NC-6004: new trials by email Literature Review of NC-6004 trials Research Report on NC-6004
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck NC-6004, Cetuximab, 5-FU - Carcinoma, Squamous Cell of Head and Neck | Phase 1 / Phase 2 | Completed | NanoCarrier Co., Ltd. | 1 | 2017-03-01 | 2019-04-29 |
| Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer NC-6004, Cetuximab, 5-FU - Head and Neck Neoplasms | Phase 1 | Terminated | Orient Europharma Co., Ltd. | 4 | 2016-06-01 | 2021-04-30 |
| Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer NC-6004, Gemcitabine - Solid Tumors | Phase 1 / Phase 2 | Completed | NanoCarrier Co., Ltd. | 119 | 2014-05-01 | 2025-01-22 |
Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
NanoCarrier Co., Ltd. (2) · Orient Europharma Co., Ltd. (1)
Bulgaria (2) · Romania (2) · United States (2) · Hungary (1) · Italy (1) · Poland (1) · Taiwan (1)
Atsushi Osada, Study Director (1) · Joao da Silva, MD (1) · Ruey-Long Hong, MD PhD (1)